Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBT with or without sertraline for obsessive-compulsive disorder
IRCT20200126046273N1Phase 2Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of sertraline in obsessive compulsive disorder (OCD) (2 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoint: Severity of obsessive-compulsive disorder. Started Sep 2019; status: completed.
02
Drugs
sertraline
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on IRCT20200126046273N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200126046273N1.